Natalia Rompoti

17PUBLICATIONS
62CO-AUTHORS
Major global burdens of diseasePersonality and individual differencesPharmacogenomicsDiagnostic radiographyRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 29, 2025
Systemic inflammation correlates with depression and lower quality of life in patients with hidradenitis suppurativa independent of disease severity.

Nikolaos Rotsiamis, Natalia Rompoti, Aikaterini Liakou

|Nov 09, 2024
Psychopathological Profile of Patients with Moderate-to-Severe Plaque Psoriasis and Its Correlation to DLQI: Results from a Prospective, Monocentric Clinical Study.

Natalia Rompoti, Sofia Tsiori, Konstantinos Kontoangelos

|Oct 16, 2024
Association between Inflammatory Markers and Psychometric Scores in Patients with Hidradenitis Suppurativa.

Aikaterini I Liakou, Nikolaos Rotsiamis, Andreas G Tsantes

|Jun 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Andrea Chiricozzi, Giulia Coscarella, Luis Puig

|Dec 23, 2022
Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks.

Natalia Rompoti, Maria Politou, Irene Stefanaki

|Jan 19, 2020
Real-world data from a single Greek centre on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response.

N Rompoti, P Sidiropoulou, P Panagakis

Pageof 3

Frequent Collaborators

6 joint publications

Electra Nicolaidou

5 joint publications

Ioannis-Alexios Koumprentziotis

4 joint publications

Stamatis Gregoriou

4 joint publications

Evangelia Papadavid